News Focus
News Focus
icon url

TampaTradr

06/12/16 9:50 PM

#266620 RE: pphmtoolong #266602

Well spoken.
icon url

exwannabe

06/12/16 10:01 PM

#266621 RE: pphmtoolong #266602

pphmtoolong, I also agree that your post was well said.

I am always a bit aghast that some investors can consider a small dev stage bio to be anything other than speculative. Decide if it is worth the risk, and go long or not. But pretending that it is certain to succeed can set one up for a big fail.

On management greed I have a different view though. What we are seeing is something that has been bread into the corporate system in the last several decades, and I think it sucks.



icon url

biopharm

06/12/16 10:31 PM

#266622 RE: pphmtoolong #266602

but whether Mother Nature wanted the anti-PS approach to be a significant cancer/virus fighter. As of now, Mother Nature has given us the cold shoulder.



I disagree 100%

Have you read the 100's of PS related publications, detailing how flipped PS "IS" is a biomarker of disease/cancer...etc ?

Even the experts agree below, see CJ's post.... and hmmm, maybe that is why NCCN, AstraZeneca and MSK jumped on board?

Are you telling me that NCCN, AstraZeneca and MSK all jump on board "highly speculative" biotechs ? : )

When some try to force the focus and say we should be seeing something else verse what I see clearly.... then I question that line of thought.

Damn... I say Fargo was because PS Targeting is "highly on target" and PS Targeting remains the target for IO combo's.

--------------------------------------------


“Phosphatidylserine is a Global Immunosuppressive Signal in Efferocytosis, Infectious Disease, and Cancer”

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120805096